Optimal Non-invasive Strategies to Reduce Recurrent Atherosclerotic Cardiovascular Disease Risk

Area of Science:

• Cardiology
• Preventive Medicine
• Pharmacology

Background:

• Cardiovascular disease (CVD) is the primary global cause of mortality, with coronary artery disease (CAD) accounting for most deaths.
• CAD incidence is rising in developing nations, and its prevalence grows globally due to aging populations.
• High risk of recurrent events persists after initial CAD manifestation.

Purpose of the Study:

• To review current risk prediction strategies for coronary artery disease (CAD).
• To explore non-invasive, non-pharmacologic, and pharmacologic interventions for mitigating residual CAD risk.
• To highlight the importance of combined therapeutic approaches in reducing recurrent cardiovascular disease (CVD) events.

Main Methods:

• Review of recent therapeutic developments in diet and lipid management.
• Analysis of advancements in managing triglycerides and glycemic control.
• Examination of antiplatelet and oral anticoagulant therapies.

Main Results:

• Significant progress has been made across multiple therapeutic areas, including lifestyle modifications and pharmacological agents.
• Integrated strategies combining tailored lifestyle interventions and pharmacotherapy offer the most effective risk reduction for recurrent CVD events.
• Risk prediction and various treatment modalities are key to managing residual CAD risk.

Conclusions:

• A multifaceted approach is essential for effective CAD management.
• Tailored lifestyle and pharmacologic interventions are critical for reducing recurrent cardiovascular events.
• Continued research into risk prediction and novel therapies is vital for improving patient outcomes in CAD.